RNU6-2
gene geneOn this page
Also known as U6-2
Summary
RNU6-2 (RNA, U6 small nuclear 2, HGNC:34270) is a small nuclear RNA gene on chromosome 19p13.3.
Predicted to enable U4 snRNA binding activity. Predicted to be involved in formation of quadruple SL/U4/U5/U6 snRNP and spliceosomal tri-snRNP complex assembly. Predicted to be part of U4/U6 x U5 tri-snRNP complex and U6 snRNP.
Source: NCBI Gene 103625684 — RefSeq curated summary.
At a glance
- Gene type: non-coding (snRNA) — no protein product; not a drug target. Variant/disease associations are omitted (they would be positional, from an overlapping protein-coding gene).
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:34270 |
| Approved symbol | RNU6-2 |
| Name | RNA, U6 small nuclear 2 |
| Location | 19p13.3 |
| Locus type | RNA, small nuclear |
| Status | Approved |
| Aliases | U6-2 |
| Ensembl gene | ENSG00000207357 |
| Ensembl biotype | snRNA |
| Entrez | 103625684 |
| RNAcentral | URS00001EC8D7 — snRNA, 107 nt, 212 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 snRNA
ENST00000384627
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
ENST00000384627 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003513160 | 1021522 | 1021628 |
Expression profiles
Bgee: expression breadth ubiquitous, 117 present calls, max score 99.60.
FANTOM5 (CAGE): breadth broad, TPM avg 2.4124 / max 468.2337, expressed in 667 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 172826 | 2.4124 | 667 |
Top tissues by expression
117 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 99.60 | gold quality |
| adrenal tissue | UBERON:0018303 | 95.53 | gold quality |
| corpus callosum | UBERON:0002336 | 90.77 | gold quality |
| granulocyte | CL:0000094 | 90.62 | gold quality |
| calcaneal tendon | UBERON:0003701 | 88.32 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 88.25 | gold quality |
| endometrium | UBERON:0001295 | 87.15 | gold quality |
| skeletal muscle tissue | UBERON:0001134 | 86.57 | gold quality |
| monocyte | CL:0000576 | 86.48 | gold quality |
| blood | UBERON:0000178 | 86.32 | gold quality |
| Ammon’s horn | UBERON:0001954 | 86.31 | gold quality |
| anterior cingulate cortex | UBERON:0009835 | 86.20 | gold quality |
| nucleus accumbens | UBERON:0001882 | 86.00 | gold quality |
| leukocyte | CL:0000738 | 85.88 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 85.62 | gold quality |
| substantia nigra | UBERON:0002038 | 85.31 | gold quality |
| hypothalamus | UBERON:0001898 | 85.19 | gold quality |
| cerebral cortex | UBERON:0000956 | 84.99 | gold quality |
| islet of Langerhans | UBERON:0000006 | 84.83 | gold quality |
| frontal cortex | UBERON:0001870 | 84.30 | gold quality |
| right frontal lobe | UBERON:0002810 | 84.22 | gold quality |
| dorsolateral prefrontal cortex | UBERON:0009834 | 84.00 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 83.99 | gold quality |
| brain | UBERON:0000955 | 83.70 | gold quality |
| caudate nucleus | UBERON:0001873 | 83.67 | gold quality |
| amygdala | UBERON:0001876 | 83.66 | gold quality |
| bone marrow | UBERON:0002371 | 83.51 | gold quality |
| putamen | UBERON:0001874 | 82.91 | gold quality |
| prefrontal cortex | UBERON:0000451 | 82.82 | gold quality |
| Brodmann (1909) area 9 | UBERON:0013540 | 82.72 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | no | 1.72 |
Regulation
Is transcription factor: no
Cross-species orthologs
1 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| mus_musculus | Gm24205 | ENSMUSG00000119461 |
Paralogs (1313): RNU6-1123P (ENSG00000199217), RNU6-500P (ENSG00000199219), RNU6-50P (ENSG00000199226), RNU6-834P (ENSG00000199237), RNU6-896P (ENSG00000199246), RNU6-28P (ENSG00000199248), RNU6-664P (ENSG00000199251), RNU6-874P (ENSG00000199260), RNU6-349P (ENSG00000199272), RNU6-661P (ENSG00000199279), RNU6-1094P (ENSG00000199286), RNU6-502P (ENSG00000199289), RNU6-1312P (ENSG00000199295), RNU6-208P (ENSG00000199301), RNU6-858P (ENSG00000199306), RNU6-222P (ENSG00000199308), RNU6-1298P (ENSG00000199326), RNU6-230P (ENSG00000199327), RNU6-204P (ENSG00000199335), RNU6-766P (ENSG00000199348), RNU6-1115P (ENSG00000199360), RNU6-1084P (ENSG00000199368), RNU6-79P (ENSG00000199381), RNU6-369P (ENSG00000199385), RNU6-600P (ENSG00000199394), RNU6-543P (ENSG00000199446), RNU6-845P (ENSG00000199448), RNU6-1216P (ENSG00000199460), RNU6-556P (ENSG00000199468), RNU6-633P (ENSG00000199482), RNU6-1313P (ENSG00000199492), RNU6-247P (ENSG00000199506), RNU6-212P (ENSG00000199512), RNU6-235P (ENSG00000199514), RNU6-386P (ENSG00000199520), RNU6-462P (ENSG00000199529), RNU6-315P (ENSG00000199536), RNU6-545P (ENSG00000199551), RNU6-37P (ENSG00000199562), RNU6-228P (ENSG00000199570)
Protein
Non-coding RNA — no protein product; not a drug target.
Function
No curated pathway, Gene-Ontology, or interaction data.
Disease & clinical
No curated disease, variant, or cancer-driver associations.
Drugs & pharmacology
No drug or pharmacology data — not an established drug target.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.